clonazepam NDC 72888-136

NDC codes

FDA NDC Directory

Product NDC (as listed)72888-136Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72888-0136Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72888-136-29	72888013629	10 TABLET, ORALLY DISINTEGRATING in 1 CARTON (72888-136-29)Marketed from May 21, 2026
72888-136-31	72888013631	6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (72888-136-31)Marketed from May 21, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): clonazepam
Generic name (nonproprietary): clonazepam
Active ingredients: Clonazepam — 1 mg/1
Dosage form: Tablet, Orally disintegrating
Route: Oral
Labeler: Advagen Pharma Ltd
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 216988
Marketing start: May 21, 2026
Listing expires: Dec 31, 2027
DEA schedule: CIV
Other FDA classes: Benzodiazepines (Chemical structure)
Identifiers: Product ID 72888-136_52c6d077-2562-84e0-e063-6394a90ae280SPL ID 52c6d077-2562-84e0-e063-6394a90ae280SPL set ID 19fc756c-72fe-4504-beaa-4fa2235af18cRxCUI 349194, 349195, 349196, 349197, 349198UNII 5PE9FDE8GBUPC 0372888136318, 0372888137315, 0372888133317
Pharmacologic class: Benzodiazepine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472888013629 followed by a unit qualifier and the quantity

Package 72888-0136-29. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 27, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Seizure Disorders: Clonazepam orally disintegrating tablet is useful alone or as an adjunct in the treatment of the Lennox- Gastaut syndrome (petit mal variant), akinetic and myoclonic seizures. In patients with absence seizures (petit mal) who have failed to respond to succinimides, clonazepam orally disintegrating tablets may be useful. In some studies, up to 30% of patients have shown a loss of anticonvulsant activity, often within 3 months of administration. In some cases, dosage adjustment may reestablish efficacy. Panic Disorder: Clonazepam orally disintegrating tablet is indicated for the treatment of panic disorder, with or without agoraphobia, as defined in DSM…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 216988

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 216988
Product	Strength	Form · route	Labeler	Product NDC
clonazepam	Clonazepam .25 mg/1	Tablet, Orally disintegratingOral	Advagen Pharma Ltd	72888-134
clonazepam	Clonazepam .125 mg/1	Tablet, Orally disintegratingOral	Advagen Pharma Ltd	72888-133
clonazepam	Clonazepam .5 mg/1	Tablet, Orally disintegratingOral	Advagen Pharma Ltd	72888-135
clonazepam	Clonazepam 2 mg/1	Tablet, Orally disintegratingOral	Advagen Pharma Ltd	72888-137